Net Income (Loss) Attributable to Parent in USD of REVELATION BIOSCIENCES, INC. from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Revelation Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2019 to Q3 2025.
  • Revelation Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$1.91M, a 14.9% increase year-over-year.
  • Revelation Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$8.13M, a 47.6% increase year-over-year.
  • Revelation Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$15M, a 12406% decline from 2023.
  • Revelation Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$120K, a 98.9% increase from 2022.
  • Revelation Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$10.8M, a 9.66% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

REVELATION BIOSCIENCES, INC. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$8.13M -$1.91M +$334K +14.9% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 -$8.46M -$2.44M +$5.95M +70.9% Apr 1, 2025 Jun 30, 2025 10-Q 2025-11-06
Q1 2025 -$14.4M -$2.05M +$630K +23.5% Jan 1, 2025 Mar 31, 2025 10-Q 2025-11-06
Q4 2024 -$15M -$1.73M +$477K +21.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-06
Q3 2024 -$15.5M -$2.24M +$387K +14.7% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 -$15.9M -$8.39M -$6.94M -479% Apr 1, 2024 Jun 30, 2024 10-Q 2025-11-06
Q1 2024 -$8.96M -$2.68M -$8.84M -144% Jan 1, 2024 Mar 31, 2024 10-Q 2025-11-06
Q4 2023 -$120K -$2.2M -$995K -82.4% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-06
Q3 2023 $875K -$2.63M -$1.46M -125% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $2.33M -$1.45M +$387K +21.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-08
Q1 2023 $1.95M $6.16M +$12.8M Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-08
Q4 2022 -$10.8M -$1.21M +$2.65M +68.7% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-09-23
Q3 2022 -$13.5M -$1.17M +$1.87M +61.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$15.4M -$1.83M +$635K +25.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$16M -$6.62M -$4M -153% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$12M -$3.86M -$2.24M -138% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$9.75M -$3.04M -$3.04M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$6.7M -$2.47M -$2.47M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$4.24M -$2.61M -$2.61M -36385% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$1.63M -$1.62M -$1.62M Oct 1, 2020 Dec 31, 2020 10-K 2022-04-15
Q3 2020 -$12.2K -$868* Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 -$521* Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
Q1 2020 -$7.16K Jan 1, 2020 Mar 31, 2020 10-Q 2021-06-22
Q4 2019 -$3.64K* Nov 20, 2019 Dec 31, 2019 10-K/A 2021-06-16

REVELATION BIOSCIENCES, INC. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$15M -$14.9M -12406% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-06
2023 -$120K +$10.7M +98.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-06
2022 -$10.8M +$1.16M +9.66% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-09-23
2021 -$12M -$10.4M -635% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$1.63M -$1.63M Jan 1, 2020 Dec 31, 2020 10-K 2022-04-15
2019 -$3.64K* Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.